UNSPSC 51201572: Vedolizumab

An integrin receptor antagonist.

UNSPSC 51201572 Vedolizumab, a Commodity code, shows no recent state and local procurement activity aligned with its scope. The three recent opportunities posted under this code involve a district attorney's dog, athletic training services, and fire-rescue medical aid supplies—none of which relate to vedolizumab, an immunosuppressant biologic medication used in gastrointestinal and rheumatologic disease management. The mismatch between the code's pharmaceutical designation and the actual work being solicited suggests either tagging errors in the opportunities or that vedolizumab procurement through state and local channels is currently inactive.

Without recent, authentic vedolizumab solicitations in the state and local record, no issuing-body pattern, geographic concentration, or market signal can be drawn. Firms pursuing government pharmaceutical supply contracts should verify the correct UNSPSC codes with state and local procurement offices and monitor health-system and Medicaid agency solicitations directly, rather than relying on this code's current posting activity.